The other side of technology: risk of overdiagnosis of breast cancer with mammography screening

被引：2

作者：

Puliti, Donella ^{[1
]}

Paci, Eugenio ^{[1
]}

机构：

[1] ISPO Canc Prevent & Res Inst, Clin & Descript Epidemiol Unit, I-50135 Florence, Italy

来源：

FUTURE ONCOLOGY | 2009年 / 5卷 / 04期

关键词：

breast cancer; cumulative-incidence method; overdiagnosis; overtreatment; service screening; CARCINOMA IN-SITU; IMPROVED SURVIVAL; PROSTATE-CANCER; MORTALITY; PROGRAM; TRIALS; OVERTREATMENT; REDUCTION; TIME; OVERDETECTION;

D O I：

10.2217/FON.09.25

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Estimates of overdiagnosis of breast cancer with mammography screening differ between studies. The estimate of overdiagnosis obtained using the cumulative incidence approach with data from randomized clinical trials ranges from 10 to 14%. In observational studies, where statistical adjustment for lead-time was utilized, the estimate was lower than 5% in two Italian studies, while it was quite higher in a Swedish study. Most of the differences are explained by different methodology, study design and measures. In this review we discuss the concept and the definition of the measure of overdiagnosis, and present different study methods to estimate overdiagnosis of breast cancer with mammography screening.

引用

页码：481 / 491

页数：11

共 41 条

[1] The screening mammography paradox: better when found, perhaps better not to find [J].

Berry, D. A. .

BRITISH JOURNAL OF CANCER, 2008, 98 (11) :1729-1730

[2] Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review [J].

Biesheuvel, Corne ;

Barratt, Alexandra ;

Howard, Kirsten ;

Houssami, Nehmat ;

Irwig, Les .

LANCET ONCOLOGY, 2007, 8 (12) :1129-1138

[3]

Blamey RW, 2002, EUR J CANCER, V38, P1458

[4] Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality [J].

Blanks, RG ;

Moss, SM ;

McGahan, CE ;

Quinn, MJ ;

Babb, PJ .

BRITISH MEDICAL JOURNAL, 2000, 321 (7262) :665-669

[5] Clinical application of the 70-gene profile: The MINDACT trial [J].

Cardoso, Fatima ;

Van't Veer, Laura ;

Rutgers, Emiel ;

Loi, Sherene ;

Mook, Stella ;

Piccart-Gebhart, Martine J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :729-735

[6] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].

Draisma, G ;

Boer, R ;

Otto, SJ ;

van der Cruijsen, IW ;

Damhuis, RAM ;

Schröder, FH ;

de Koning, HJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878

[7] Complexities in the estimation of overdiagnosis in breast cancer screening [J].

Duffy, S. W. ;

Lynge, E. ;

Jonsson, H. ;

Ayyaz, S. ;

Olsen, A. H. .

BRITISH JOURNAL OF CANCER, 2008, 99 (07) :1176-1178

[8]

Duffy SW, 2006, J MED SCREEN, V13, pS28

[9] Reduction in breast cancer mortality from organized service screening with mammography:: 1.: Further confirmation with extended data [J].

Duffy, SW ;

Tabár, L ;

Chen, THH ;

Smith, RA ;

Holmberg, L ;

Jonsson, H ;

Lenner, P ;

Nyström, L ;

Törnberg, S .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) :45-51

[10] Overdiagnosis and overtreatment of breast cancer -: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer [J].

Duffy, SW ;

Agbaje, O ;

Tabar, L ;

Vitak, B ;

Bjurstam, N ;

Björneld, L ;

Myles, JP ;

Warwick, J .

BREAST CANCER RESEARCH, 2005, 7 (06) :258-265

← 1 2 3 4 5 →